As of December 2025 Regentis Biomaterials has a market cap of A$51.39 Million. This makes Regentis Biomaterials the world's 9986th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.